Insider Transactions in Q4 2024 at Volitionrx LTD (VNRX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2024
|
Cameron John Reynolds President and CEO |
BUY
Open market or private purchase
|
Direct |
139,811
+6.19%
|
$0
$0.57 P/Share
|
|
Dec 09
2024
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
43,691
+9.97%
|
$0
$0.57 P/Share
|
|
Dec 09
2024
|
Timothy I Still |
BUY
Open market or private purchase
|
Direct |
87,382
+5.55%
|
$0
$0.57 P/Share
|
|
Dec 09
2024
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
174,764
+22.07%
|
$0
$0.57 P/Share
|
|
Dec 01
2024
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Grant, award, or other acquisition
|
Direct |
16,871
+5.43%
|
-
|
|
Dec 01
2024
|
Andrew Retter Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,365
+6.84%
|
-
|
|
Dec 01
2024
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,683
+3.26%
|
-
|
|
Dec 01
2024
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
8,648
+10.15%
|
-
|
|
Dec 01
2024
|
Ann Louise Batchelor Group Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,143
+10.28%
|
-
|
|
Dec 01
2024
|
Alan Colman |
BUY
Grant, award, or other acquisition
|
Direct |
12,972
+5.33%
|
-
|
|
Dec 01
2024
|
Jasmine Kway CEO, Singapore Volition |
BUY
Grant, award, or other acquisition
|
Direct |
15,169
+8.37%
|
-
|
|
Dec 01
2024
|
Ethel Rubin |
BUY
Grant, award, or other acquisition
|
Direct |
8,648
+26.78%
|
-
|
|
Dec 01
2024
|
Gael Forterre Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,828
+2.98%
|
-
|
|
Dec 01
2024
|
Guy Archibald Innes |
BUY
Grant, award, or other acquisition
|
Direct |
17,296
+3.76%
|
-
|
|
Dec 01
2024
|
Nicholas Plummer GC, Volition Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
11,527
+6.52%
|
-
|
|
Dec 01
2024
|
Rodney Gerard Rootsaert Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
7,302
+5.13%
|
-
|
|
Nov 06
2024
|
Timothy I Still |
BUY
Grant, award, or other acquisition
|
Direct |
1,400,000
+45.83%
|
-
|
|
Oct 04
2024
|
Jacob Vincent Micallef Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,200
-1.46%
|
$0
$0.88 P/Share
|
|
Oct 04
2024
|
Nicholas Plummer GC, Volition Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
8,146
-5.04%
|
$0
$0.88 P/Share
|
|
Oct 04
2024
|
Gael Forterre Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,433
-3.44%
|
$0
$0.88 P/Share
|
|
Oct 04
2024
|
Rodney Gerard Rootsaert Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,620
-3.49%
|
$0
$0.88 P/Share
|
|
Oct 04
2024
|
Ann Louise Batchelor Group Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,110
-5.67%
|
$0
$0.88 P/Share
|
|
Oct 04
2024
|
Salvatore Thomas Butera CEO, Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,834
-2.06%
|
$0
$0.88 P/Share
|